 
                        | Product NDC: | 0093-7113 | 
| Proprietary Name: | Nefazodone Hydrochloride | 
| Non Proprietary Name: | Nefazodone Hydrochloride | 
| Active Ingredient(s): | 150 mg/1 & nbsp; Nefazodone Hydrochloride | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0093-7113 | 
| Labeler Name: | Teva Pharmaceuticals USA Inc | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA076037 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20030916 | 
| Package NDC: | 0093-7113-06 | 
| Package Description: | 60 TABLET in 1 BOTTLE (0093-7113-06) | 
| NDC Code | 0093-7113-06 | 
| Proprietary Name | Nefazodone Hydrochloride | 
| Package Description | 60 TABLET in 1 BOTTLE (0093-7113-06) | 
| Product NDC | 0093-7113 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Nefazodone Hydrochloride | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20030916 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Teva Pharmaceuticals USA Inc | 
| Substance Name | NEFAZODONE HYDROCHLORIDE | 
| Strength Number | 150 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC] |